§ COMPARE REGULATORS

PMDA vs CDSCO: Medical Device Regulatory Comparison

Compare the medical device registration pathways, classification, and regulatory requirements of PMDA (Japan) vs CDSCO (India).

PMDA

Pharmaceuticals and Medical Devices Agency (Japan)

Japan

Japan's PMDA conducts scientific reviews of medical device applications under the PMD Act. Japan uses a four-class system with three pathways: Todokede (notification) for Class I, Ninsho (third-party

CLASSES

Class I, II, III, IV

PATHWAY

Todokede / Ninsho / Shonin

KEY FUNCTIONS
  • Shonin pre-market approval
  • Ninsho third-party certification
  • QMS inspection (MHLW Ordinance 169)
  • PMDA consultation (Taimen Joshu)
  • Foreign Manufacturer Registration

CDSCO

Central Drugs Standard Control Organization (India)

India

India's CDSCO regulates medical devices under the Medical Devices Rules 2017 (amended 2020). India uses a four-class system (A, B, C, D). India is the fastest-growing major medical device market globa

CLASSES

Class A, B, C, D

PATHWAY

CDSCO registration / import license

KEY FUNCTIONS
  • Medical device registration
  • Import license (Form MD-14)
  • Clinical investigation approval
  • Quality management system audit
  • Adverse event reporting

MedFlux monitors both PMDA and CDSCO in real time — every regulatory change, safety alert, and market signal delivered in under 90 seconds.

COMPARE LIVE DATA FREE →

§ OTHER COMPARISONS